Association of hyperuricemia and pulmonary hypertension: A systematic review and meta-analysis
Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH. Methods: The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric ac...
Saved in:
Published in | Modern rheumatology Vol. 29; no. 6; pp. 1031 - 1041 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
02.11.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 1439-7595 1439-7609 1439-7609 |
DOI | 10.1080/14397595.2018.1537555 |
Cover
Abstract | Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH.
Methods: The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric acid (UA) levels with the presence of PH; (2) association between serum UA levels and subsequent development of PH, in terms of odds ratio of the development of PH; and (3) association of serum UA levels with severity and prognosis of PH, in terms of pulmonary arterial pressure and hazard ratio of death.
Results: Twenty-six studies published between 1999 and 2017 were included. The level of serum UA was higher in subjects with PH than subjects without PH and this finding was observed regardless of status of diuretics use or renal function. The odds ratio of the development of PH was 2.32 (95% CI, 1.05-5.15) in subjects with hyperuricemia. Pulmonary arterial pressure among subjects with PH was also higher in subjects with hyperuricemia than subjects with normouricemia. There was a 19% increased hazard ratio of death (95% CI, 1.06-1.33) among patients with PH who had hyperuricemia.
Conclusion: Hyperuricemia is associated with the subsequent development, worse severity and poor prognosis of PH. |
---|---|
AbstractList | To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH.
The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric acid (UA) levels with the presence of PH; (2) association between serum UA levels and subsequent development of PH, in terms of odds ratio of the development of PH; and (3) association of serum UA levels with severity and prognosis of PH, in terms of pulmonary arterial pressure and hazard ratio of death.
Twenty-six studies published between 1999 and 2017 were included. The level of serum UA was higher in subjects with PH than subjects without PH and this finding was observed regardless of status of diuretics use or renal function. The odds ratio of the development of PH was 2.32 (95% CI, 1.05-5.15) in subjects with hyperuricemia. Pulmonary arterial pressure among subjects with PH was also higher in subjects with hyperuricemia than subjects with normouricemia. There was a 19% increased hazard ratio of death (95% CI, 1.06-1.33) among patients with PH who had hyperuricemia.
Hyperuricemia is associated with the subsequent development, worse severity and poor prognosis of PH. Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH.Methods: The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric acid (UA) levels with the presence of PH; (2) association between serum UA levels and subsequent development of PH, in terms of odds ratio of the development of PH; and (3) association of serum UA levels with severity and prognosis of PH, in terms of pulmonary arterial pressure and hazard ratio of death.Results: Twenty-six studies published between 1999 and 2017 were included. The level of serum UA was higher in subjects with PH than subjects without PH and this finding was observed regardless of status of diuretics use or renal function. The odds ratio of the development of PH was 2.32 (95% CI, 1.05-5.15) in subjects with hyperuricemia. Pulmonary arterial pressure among subjects with PH was also higher in subjects with hyperuricemia than subjects with normouricemia. There was a 19% increased hazard ratio of death (95% CI, 1.06-1.33) among patients with PH who had hyperuricemia.Conclusion: Hyperuricemia is associated with the subsequent development, worse severity and poor prognosis of PH.Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH.Methods: The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric acid (UA) levels with the presence of PH; (2) association between serum UA levels and subsequent development of PH, in terms of odds ratio of the development of PH; and (3) association of serum UA levels with severity and prognosis of PH, in terms of pulmonary arterial pressure and hazard ratio of death.Results: Twenty-six studies published between 1999 and 2017 were included. The level of serum UA was higher in subjects with PH than subjects without PH and this finding was observed regardless of status of diuretics use or renal function. The odds ratio of the development of PH was 2.32 (95% CI, 1.05-5.15) in subjects with hyperuricemia. Pulmonary arterial pressure among subjects with PH was also higher in subjects with hyperuricemia than subjects with normouricemia. There was a 19% increased hazard ratio of death (95% CI, 1.06-1.33) among patients with PH who had hyperuricemia.Conclusion: Hyperuricemia is associated with the subsequent development, worse severity and poor prognosis of PH. Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH. Methods: The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric acid (UA) levels with the presence of PH; (2) association between serum UA levels and subsequent development of PH, in terms of odds ratio of the development of PH; and (3) association of serum UA levels with severity and prognosis of PH, in terms of pulmonary arterial pressure and hazard ratio of death. Results: Twenty-six studies published between 1999 and 2017 were included. The level of serum UA was higher in subjects with PH than subjects without PH and this finding was observed regardless of status of diuretics use or renal function. The odds ratio of the development of PH was 2.32 (95% CI, 1.05-5.15) in subjects with hyperuricemia. Pulmonary arterial pressure among subjects with PH was also higher in subjects with hyperuricemia than subjects with normouricemia. There was a 19% increased hazard ratio of death (95% CI, 1.06-1.33) among patients with PH who had hyperuricemia. Conclusion: Hyperuricemia is associated with the subsequent development, worse severity and poor prognosis of PH. |
Author | Uk Kang, Tae Ahn, Hyeong Sik Jun, Jae-Bum Park, Kyu Yong Yim, Shin-Young Kim, Hyun Jung |
Author_xml | – sequence: 1 givenname: Tae orcidid: 0000-0003-1467-2281 surname: Uk Kang fullname: Uk Kang, Tae organization: Health Insurance Policy Research Institute, National Health Insurance Service – sequence: 2 givenname: Kyu Yong surname: Park fullname: Park, Kyu Yong organization: Department of Physical Medicine and Rehabilitation, Ajou University School of Medicine, Suwon – sequence: 3 givenname: Hyun Jung orcidid: 0000-0003-2018-2385 surname: Kim fullname: Kim, Hyun Jung organization: Department of Preventive Medicine, College of Medicine, Korea University – sequence: 4 givenname: Hyeong Sik orcidid: 0000-0002-2084-7466 surname: Ahn fullname: Ahn, Hyeong Sik organization: Department of Preventive Medicine, College of Medicine, Korea University – sequence: 5 givenname: Shin-Young orcidid: 0000-0002-8521-6331 surname: Yim fullname: Yim, Shin-Young email: syyim@ajou.ac.kr organization: Department of Physical Medicine and Rehabilitation, Ajou University School of Medicine, Suwon – sequence: 6 givenname: Jae-Bum orcidid: 0000-0002-0208-0505 surname: Jun fullname: Jun, Jae-Bum email: junjb@hanyang.ac.kr organization: Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30334638$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUFv2yAYhtHUam2z_YRNPvbiDIyxTXdpVHVbpUi9tNehL_ChMdmQAW7lf1-nSS49rCcQPM-L-N4LcuKDR0K-MLpktKPfWM1lK6RYVpR1SyZ4K4T4QM5352XbUHly3M_QGblI6S-lXMhOfiRnnHJeN7w7J79XKQXtILvgi2CLP9MW4xidxsFBAd4U27Efgoc47e8y-jSzV8WqSFPKOMyqLiI-OXx-5QfMUIKHfkoufSKnFvqEnw_rgjz-uH24-VWu73_e3azWpa5Fk8vKNMaAsbJuKKsqTqUQ1IIGoTctUkCUGyaEphxrVlHERjNTGVlZw7hpLV-Qy33uNoZ_I6asBpc09j14DGNS1ZwqOkFlPaNfD-i4GdCobXTD_Dt1nMkMfN8DOoaUIlqlXX4dUI7gesWo2jWgjg2oXQPq0MBsizf28YH3vOu957wNcYDnEHujMkx9iDaC1y4p_v-IF4M0nlM |
CitedBy_id | crossref_primary_10_1159_000506596 crossref_primary_10_1016_j_hlc_2023_10_020 crossref_primary_10_1097_MD_0000000000031587 crossref_primary_10_3390_jcm12155034 crossref_primary_10_14423_SMJ_0000000000001494 crossref_primary_10_4103_ejh_ejh_92_23 crossref_primary_10_1038_s41392_024_01916_y crossref_primary_10_3389_fmed_2022_805415 crossref_primary_10_1183_13993003_00332_2020 crossref_primary_10_3892_etm_2024_12459 crossref_primary_10_1038_s41598_025_88887_4 crossref_primary_10_1161_HYPERTENSIONAHA_120_14525 crossref_primary_10_12677_jcpm_2024_32072 crossref_primary_10_1097_HJH_0000000000003807 crossref_primary_10_1038_s41598_024_53077_1 crossref_primary_10_1016_j_rdc_2019_04_005 crossref_primary_10_38109_2075_082X_2024_1_37_46 crossref_primary_10_12677_ACM_2023_1381862 crossref_primary_10_5812_mca_97040 crossref_primary_10_3390_medicina61010019 crossref_primary_10_1016_j_hrtlng_2024_08_018 crossref_primary_10_3892_mmr_2023_13133 |
Cites_doi | 10.1161/CIRCULATIONAHA.114.006971 10.1378/chest.117.1.19 10.1056/NEJMra0800885 10.1016/j.vph.2016.08.009 10.1006/abbi.1993.1204 10.1056/NEJM196609012750902 10.1007/s00408-015-9694-x 10.1164/ajrccm/148.1.173 10.3310/hta7270 10.1053/rmed.2003.1440 10.1097/00029330-200812020-00006 10.1016/j.pharmthera.2016.12.004 10.1164/ajrccm.160.2.9812078 10.1016/j.rdc.2015.01.003 10.1016/j.crvi.2004.05.007 10.1016/0022-2828(89)90610-X 10.1016/j.transproceed.2014.10.070 10.7326/0003-4819-34-6-1421 10.1016/j.rmed.2012.09.003 10.1097/MD.0000000000002761 10.1136/annrheumdis-2013-203301 10.1253/circj.CJ-11-1237 10.1056/NEJM198501173120305 10.1203/PDR.0b013e318163a2e7 10.3892/etm.2015.2376 10.1536/ihj.48.523 10.1001/jama.300.8.924 10.17116/terarkh201587149-56 10.1080/15257770802138558 10.1016/j.semarthrit.2016.01.003 10.1016/j.mehy.2009.12.023 10.1073/pnas.78.11.6858 10.1097/RHU.0000000000000496 10.1007/s12288-011-0072-4 10.1016/j.healun.2014.01.853 10.1183/09031936.99.13368299 10.1378/chest.10-3331 10.1177/0961203315600539 10.1016/j.jclinepi.2009.06.005 10.1253/circj.CJ-11-1223 10.1097/00005344-200109000-00005 10.1007/s00296-010-1557-4 10.1111/1756-185X.12262 10.1136/heart.84.1.53 10.1093/eurheartj/ehp297 |
ContentType | Journal Article |
Copyright | 2018 Japan College of Rheumatology 2018 |
Copyright_xml | – notice: 2018 Japan College of Rheumatology 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1080/14397595.2018.1537555 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1439-7609 |
EndPage | 1041 |
ExternalDocumentID | 30334638 10_1080_14397595_2018_1537555 1537555 |
Genre | Article Meta-Analysis Systematic Review Journal Article |
GrantInformation_xml | – fundername: Hanyang University grantid: HY-2014 |
GroupedDBID | --- .55 .86 00X 0R~ 0VY 123 1N0 29M 2~H 36B 4.4 53G 5WD 6NX 8TC AABZA AACZT AALUX AAPXW AARHZ AAUAY AAVAP ABEIZ ABEJV ABJNI ABNHQ ABPQP ABPTD ABQNK ABUPF ABXVV ACENM ACGFS ADCVX ADINQ ADIPN ADQBN ADRBQ ADVEK AECIN AENEX AFBBN AFFZL AGUTN AGYJP AHBYD AHMBA AHMMS AIJEM AJEEA ALIPV ALMA_UNASSIGNED_HOLDINGS ALQZU ATGXG BABNJ BCRHZ BEYMZ BGNMA BLEHA BOHLJ CCCUG CS3 DKSSO DU5 EBS EMB EMOBN F5P H13 HF~ HZ~ IHE IZQ KBUDW KDC KOP KPH KRBQP KSI KSN KSSTO KWAYT KYCEM LAS LJTGL M4Y M4Z NOMLY NU- NU0 O9- OAM OAUYM OCZFY OJZSN OPAEJ OVD OWPYF P2P Q2X R9I RNS ROX RSV S27 SDH SMD SOJ SV3 T13 TDBHL TEORI TFDNU TFL TFW TT1 V1S WK8 X7M AAYXX ABDFA ABGNP ABVGC ADNBA ADVOB AEMQT AFXAL AJNCP ALXQX CITATION -Y2 2JY 2P1 2VQ 30V 408 409 40D 5VS 67Z 7X7 88E 8AO 8FI 8FJ 8G5 8UJ 95. 95~ AAIAL AANXM AARHV AAYZH ABMNI ABTEG ABUWG ACKZS ACOMO ADBBV ADFZZ ADKPE ADQRH ADRFC AFKRA AFLOW AGJBK AHSBF AMKLP ASPBG AVWKF AZFZN AZQEC BA0 BENPR BPHCQ BVXVI CAG CCPQU CGR COF CSCUP CUY CVF CZDIS DL5 DRXRE DWQXO DWTOO ECM EIF EJD EN4 FEDTE FYUFA GNUQQ GUQSH GXS HG5 HG6 HMCUK HMJXF HVGLF I09 IXC IXE IZIGR I~X M1P M2O MA- NB0 NPM O93 O9I P9S PADUT PHGZT PQQKQ PROAC PSQYO QOS RIG ROL RPX S1Z S37 S3B TSK TSV TUC U2A UKHRP VC2 WJK Z45 ~A9 7X8 |
ID | FETCH-LOGICAL-c456t-2d6ddadf9460122309550faca5cb7e0aee9b155c03e4120ee6c1d2d92fd13d7f3 |
ISSN | 1439-7595 1439-7609 |
IngestDate | Sun Sep 28 09:06:40 EDT 2025 Thu Apr 03 07:06:18 EDT 2025 Wed Oct 01 02:16:03 EDT 2025 Thu Apr 24 22:57:57 EDT 2025 Wed Dec 25 09:07:45 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | hyperuricemia prognosis uric acid Pulmonary hypertension |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c456t-2d6ddadf9460122309550faca5cb7e0aee9b155c03e4120ee6c1d2d92fd13d7f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-2084-7466 0000-0002-0208-0505 0000-0002-8521-6331 0000-0003-2018-2385 0000-0003-1467-2281 |
PMID | 30334638 |
PQID | 2122585094 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | crossref_citationtrail_10_1080_14397595_2018_1537555 crossref_primary_10_1080_14397595_2018_1537555 pubmed_primary_30334638 informaworld_taylorfrancis_310_1080_14397595_2018_1537555 proquest_miscellaneous_2122585094 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-11-02 |
PublicationDateYYYYMMDD | 2019-11-02 |
PublicationDate_xml | – month: 11 year: 2019 text: 2019-11-02 day: 02 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Modern rheumatology |
PublicationTitleAlternate | Mod Rheumatol |
PublicationYear | 2019 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | CIT0032 CIT0031 CIT0034 CIT0033 CIT0036 CIT0035 CIT0038 CIT0037 CIT0039 Zhang CY (CIT0022) 2013; 18 CIT0041 CIT0040 CIT0042 CIT0001 CIT0045 CIT0044 CIT0003 CIT0047 CIT0002 CIT0046 CIT0005 CIT0049 CIT0004 CIT0048 CIT0007 CIT0006 CIT0009 Li ZN (CIT0029) 2012; 92 CIT0008 CIT0050 Hasday JD (CIT0043) 1987; 135 CIT0051 CIT0010 Amariei DE (CIT0023) 2015; 191 CIT0012 CIT0011 Ozpelit E (CIT0030) 2017; 14 CIT0014 CIT0013 CIT0016 CIT0015 CIT0018 CIT0017 CIT0019 CIT0021 CIT0020 Jasiewicz M (CIT0027) 2015; 73 CIT0025 CIT0024 CIT0026 CIT0028 |
References_xml | – ident: CIT0008 doi: 10.1161/CIRCULATIONAHA.114.006971 – ident: CIT0014 doi: 10.1378/chest.117.1.19 – ident: CIT0038 doi: 10.1056/NEJMra0800885 – ident: CIT0026 doi: 10.1016/j.vph.2016.08.009 – ident: CIT0039 doi: 10.1006/abbi.1993.1204 – volume: 18 start-page: e37 year: 2013 ident: CIT0022 publication-title: Exp Clin Cardiol – ident: CIT0037 doi: 10.1056/NEJM196609012750902 – ident: CIT0017 doi: 10.1007/s00408-015-9694-x – ident: CIT0042 doi: 10.1164/ajrccm/148.1.173 – ident: CIT0016 doi: 10.3310/hta7270 – ident: CIT0003 doi: 10.1053/rmed.2003.1440 – ident: CIT0019 doi: 10.1097/00029330-200812020-00006 – ident: CIT0049 doi: 10.1016/j.pharmthera.2016.12.004 – ident: CIT0013 doi: 10.1164/ajrccm.160.2.9812078 – ident: CIT0009 doi: 10.1016/j.rdc.2015.01.003 – ident: CIT0044 doi: 10.1016/j.crvi.2004.05.007 – volume: 14 start-page: 20 year: 2017 ident: CIT0030 publication-title: J Geriatr Cardiol – ident: CIT0040 doi: 10.1016/0022-2828(89)90610-X – volume: 191 start-page: A4829 year: 2015 ident: CIT0023 publication-title: Am Thoracic Soc – volume: 92 start-page: 3261 year: 2012 ident: CIT0029 publication-title: Zhonghua Yi Xue Za Zhi – ident: CIT0018 doi: 10.1016/j.transproceed.2014.10.070 – ident: CIT0036 doi: 10.7326/0003-4819-34-6-1421 – ident: CIT0002 doi: 10.1016/j.rmed.2012.09.003 – ident: CIT0006 doi: 10.1097/MD.0000000000002761 – ident: CIT0010 doi: 10.1136/annrheumdis-2013-203301 – ident: CIT0034 doi: 10.1253/circj.CJ-11-1237 – ident: CIT0041 doi: 10.1056/NEJM198501173120305 – ident: CIT0012 doi: 10.1203/PDR.0b013e318163a2e7 – ident: CIT0025 doi: 10.3892/etm.2015.2376 – ident: CIT0020 doi: 10.1536/ihj.48.523 – ident: CIT0050 doi: 10.1001/jama.300.8.924 – ident: CIT0033 doi: 10.17116/terarkh201587149-56 – ident: CIT0046 doi: 10.1080/15257770802138558 – volume: 135 start-page: 534 issue: 3 year: 1987 ident: CIT0043 publication-title: Am Rev Respir Dis – ident: CIT0051 doi: 10.1016/j.semarthrit.2016.01.003 – ident: CIT0045 doi: 10.1016/j.mehy.2009.12.023 – ident: CIT0048 doi: 10.1073/pnas.78.11.6858 – ident: CIT0035 doi: 10.1097/RHU.0000000000000496 – ident: CIT0007 doi: 10.1007/s12288-011-0072-4 – ident: CIT0024 doi: 10.1016/j.healun.2014.01.853 – volume: 73 start-page: 286 year: 2015 ident: CIT0027 publication-title: Cytokine – ident: CIT0011 doi: 10.1183/09031936.99.13368299 – ident: CIT0031 doi: 10.1378/chest.10-3331 – ident: CIT0004 doi: 10.1177/0961203315600539 – ident: CIT0015 doi: 10.1016/j.jclinepi.2009.06.005 – ident: CIT0032 doi: 10.1253/circj.CJ-11-1223 – ident: CIT0047 doi: 10.1097/00005344-200109000-00005 – ident: CIT0005 doi: 10.1007/s00296-010-1557-4 – ident: CIT0028 doi: 10.1111/1756-185X.12262 – ident: CIT0021 doi: 10.1136/heart.84.1.53 – ident: CIT0001 doi: 10.1093/eurheartj/ehp297 |
SSID | ssj0035989 |
Score | 2.320212 |
SecondaryResourceType | review_article |
Snippet | Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH.... To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH. The authors... Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of... |
SourceID | proquest pubmed crossref informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1031 |
SubjectTerms | Female Humans Hypertension, Pulmonary - blood Hypertension, Pulmonary - complications Hypertension, Pulmonary - epidemiology hyperuricemia Hyperuricemia - blood Hyperuricemia - complications Hyperuricemia - epidemiology Male Middle Aged Odds Ratio Prognosis Pulmonary hypertension uric acid Uric Acid - blood |
Title | Association of hyperuricemia and pulmonary hypertension: A systematic review and meta-analysis |
URI | https://www.tandfonline.com/doi/abs/10.1080/14397595.2018.1537555 https://www.ncbi.nlm.nih.gov/pubmed/30334638 https://www.proquest.com/docview/2122585094 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1439-7609 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0035989 issn: 1439-7595 databaseCode: AFBBN dateStart: 19970301 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB6FVEJcEDtl0yBxixy8jj3cXEQVtWqFRCKVC9azPVartk4V7EP7R_p3ebPYGdNAKRcrmmSex35f5i3zFkI-MIAiqCpwCmCVE0pzB4BFThglQpabS0omc4cPDtlsEe4dRUej0bUVtdQ2-bS42phX8j9cxTHkq8ySvQNne6I4gJ-Rv3hFDuP1n3hsvVul9KFNuVJVgs51qtXkoj3DxcjAOPWdilbXsRzpjRrOOjT4XDTggKlUYmuupmna6li0OGngjF-cTvaN23kOPVC-mijs_ct28n1pBCT0_Ztnl2092WvX4-lxrceFbH_07eTUdkh4XGXmWT5K1MC4E0e6d-ZUWGPM5fbGa1wdJzd2Udl6wpLIaDF6G3d7HR4pacvbyTi9ZIo7eBxF0Vq8dUf6v0m9PhbRM0VSOzKZJJMZMvfIlh8z5o_JVrq7s3PYCXlZ95CrxDXzrF1yWOJ-3LiegdozKIr7Z9NGqTjzR-ShsU1oqoH2mIxE_YTcPzDRF0_JDwtvdFnRAd4ooof2eKM23j7RlK7RRjXa1O8HaHtGFrtf5p9njunP4RSodjeOX7KyhLLiIZMHtIGsZuhWUEBU5LFwQQieo7pauIEIPd8VghVe6Zfcr0ovKOMqeE7G9bIWLwnNc_BVmjb4RZjHPvAEeFUGKBQgERBuk7B7fVlhitfLHipn2V_Zt02m_bQLXb3ltgnc5k3WKLdZpXvcZMEtc993jMxwj5YHb1CLZfszQ_XQR7Pc5fgcLzSH--WgChmEKARf3XWpr8mD9b_vDRk3q1a8RQW5yd8ZsP4CR7Oy9Q |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+hyperuricemia+and+pulmonary+hypertension%3A+A+systematic+review+and+meta-analysis&rft.jtitle=Modern+rheumatology&rft.au=Uk+Kang%2C+Tae&rft.au=Park%2C+Kyu+Yong&rft.au=Kim%2C+Hyun+Jung&rft.au=Ahn%2C+Hyeong+Sik&rft.date=2019-11-02&rft.issn=1439-7595&rft.eissn=1439-7609&rft.volume=29&rft.issue=6&rft.spage=1031&rft.epage=1041&rft_id=info:doi/10.1080%2F14397595.2018.1537555&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_14397595_2018_1537555 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1439-7595&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1439-7595&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1439-7595&client=summon |